文献速递脑血管病外科神经重症

破裂后超过72小时行显微手术治疗破裂动脉瘤:对进阶管理的意义

Microsurgical treatment of ruptured aneurysms beyond 72 hours after rupture: implications for advanced management.
PubMed 文献 · Acta Neurochir (Wien) · 2022-06-23

该回顾性单中心研究纳入2007年8月1日至2019年7月31日收治的956例动脉瘤性蛛网膜下腔出血(aSAH)患者,其中92例(10%)接受延迟(≥第4病日)手术治疗,864例(90%)接受急性期(≤第3病日)血管内或手术治疗。倾向性校正后,延迟组残留动脉瘤(OR=0.09;95%CI=0.04-0.17;p<0.001)和再治疗(OR=0.14;95%CI=0.06-0.29;p<0.001)的比值显著更低,再破裂OR=0.50(p=0.03)。作者认为,在校正初始疾病严重程度和显著混杂变量后,延迟显微外科管理在再治疗、残留和再破裂事件方面似乎非劣。

要点

  • 956例aSAH中92例(10%)接受延迟(≥第4病日)手术,864例(90%)接受急性期治疗。
  • 倾向性校正后延迟组残留动脉瘤OR=0.09(95%CI=0.04-0.17;p<0.001)、再治疗OR=0.14(95%CI=0.06-0.29;p<0.001)显著更低。
  • 再破裂:急性组3%(26/864) vs 延迟组1%(1/92),p=0.51;校正后延迟组再破裂OR=0.50(p=0.03)。

核心结论

  • 作者认为,在校正初始疾病严重程度和显著混杂变量后,本队列中延迟显微外科管理在再治疗、残留和再破裂事件方面似乎非劣。

研究设计与样本

  • 单中心回顾性研究,纳入2007年8月1日至2019年7月31日收治的956例aSAH患者。
  • 附加纳入标准为可获得相对于出血时间的治疗数据;按出血至治疗时间分为急性治疗组(≤第3病日)和延迟治疗组(≥第4病日)。
  • 使用倾向性校正纠正统计学显著的混杂协变量。

主要发现

  • 956例中92例(10%)接受延迟手术治疗(延迟组),864例(90%)接受急性期血管内或手术治疗(急性组)。
  • 再破裂:急性组3%(26/864) vs 延迟组1%(1/92),p=0.51。
  • 倾向性校正后,延迟组残留动脉瘤OR=0.09(95%CI=0.04-0.17;p<0.001),再治疗OR=0.14(95%CI=0.06-0.29;p<0.001),均显著更低。
  • 倾向性校正后,延迟组再破裂OR=0.50(p=0.03)。
  • 入院平均格拉斯哥昏迷评分:急性组11.5 vs 延迟组13.2,p<0.001。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Aneurysmal subarachnoid hemorrhage (aSAH) patients admitted to primary stroke centers are often transferred to neurosurgical and endovascular services at tertiary centers. The effect on microsurgical outcomes of the resultant delay in treatment is unknown. We evaluated microsurgical aSAH treatment > 72 h after the ictus. METHODS: All aSAH patients treated at a single tertiary center between August 1, 2007, and July 31, 2019, were retrospectively reviewed. The additional inclusion criterion was the availability of treatment data relative to time of bleed. Patients were grouped based on bleed-to-treatment time as having acute treatment (on or before postbleed day [PBD] 3) or delayed treatment (on or after PBD 4). Propensity adjustments were used to correct for statistically significant confounding covariables. RESULTS: Among 956 aSAH patients, 92 (10%) received delayed surgical treatment (delayed group), and 864 (90%) received acute endovascular or surgical treatment (acute group). Reruptures occurred in 3% (26/864) of the acute group and 1% (1/92) of the delayed group (p = 0.51). After propensity adjustments, the odds of residual aneurysm (OR = 0.09; 95% CI = 0.04-0.17; p < 0.001) or retreatment (OR = 0.14; 95% CI = 0.06-0.29; p < 0.001) was significantly lower among the delayed group. The OR was 0.50 for rerupture, after propensity adjustments, in the delayed setting (p = 0.03). Mean Glasgow Coma Scale scores at admission in the acute and delayed groups were 11.5 and 13.2, respectively (p < 0.001). CONCLUSIONS: Delayed microsurgical management of aSAH, if required for definitive treatment, appeared to be noninferior with respect to retreatment, residual, and rerupture events in our cohort after adjusting for initial disease severity and significant confounding variables.

来源:Acta Neurochir (Wien),查看原文。版权归原作者所有。

引用

  1. Srinivasan VM, Koester SW, Karahalios K, et al. Microsurgical treatment of ruptured aneurysms beyond 72 hours after rupture: implications for advanced management. Acta Neurochir (Wien). 2022. PMID: 35732841. doi:10.1007/s00701-022-05283-x

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。